Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc (GHDX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1131324.
Total stock buying since 2010: $274,431,226.
Total stock sales since 2010: $560,218,490.
Total stock option exercises since 2010: $58,217,068.
▪ Recent SEC 13D filings for GHDX
▪ Recent SEC 13D filings for all companies
▪ Funds & ETFs holding GHDX
▪ Recent portfolio reports of all companies
A schedule 13D must be filed with the SEC when a person or group of people acquire beneficial ownership of more than 5% of Genomic Health Inc (GHDX). A schedule 13D/A is an amendment that is filed when there are any material changes in beneficial ownership.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 37,643,330 | $0 | 4,255,395 | $302,840,723 | 1,177,273 | $31,943,202 |
| 2018 | 0 | $0 | 2,775,805 | $206,377,815 | 561,292 | $12,545,100 |
| 2017 | 0 | $0 | 218,781 | $6,847,246 | 255,541 | $4,916,282 |
| 2016 | 100,000 | $2,701,600 | 148,242 | $4,293,432 | 181,950 | $3,190,607 |
| 2015 | 0 | $0 | 65,864 | $1,910,548 | 65,864 | $879,494 |
| 2014 | 0 | $0 | 129,133 | $3,710,512 | 127,821 | $901,597 |
| 2013 | 1,291,008 | $44,806,297 | 180,546 | $5,712,858 | 147,830 | $1,549,708 |
| 2012 | 4,285,949 | $123,323,993 | 473,515 | $14,642,933 | 90,100 | $812,659 |
| 2011 | 3,431,794 | $90,242,252 | 411,096 | $10,178,567 | 124,276 | $830,861 |
| 2010 | 916,315 | $13,357,084 | 230,750 | $3,703,856 | 102,234 | $647,558 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-07-01 | Shak Steven (EVP of R&D) | Sale | 7,000 | 27.00 | 188,972 |
| 2014-07-01 | Shak Steven (EVP of R&D) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2014-06-12 | Shak Steven (EVP of R&D) | Sale | 7,000 | 26.68 | 186,739 |
| 2014-06-12 | Shak Steven (EVP of R&D) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2014-06-12 | Popovits Kimberly J (President and CEO) | Sale | 3,000 | 26.10 | 78,294 |
| 2014-06-12 | Popovits Kimberly J (President and CEO) | Option Ex | 3,000 | 9.39 | 28,170 |
| 2014-06-10 | Schorno Dean L (CFO) | Sale | 4,000 | 27.62 | 110,488 |
| 2014-06-10 | Schorno Dean L (CFO) | Option Ex | 4,000 | 18.04 | 72,140 |
| 2014-06-09 | Cole G Bradley (COO) | Sale | 2,337 | 27.29 | 63,767 |
| 2014-06-09 | Cole G Bradley (COO) | Option Ex | 2,337 | 2.88 | 6,730 |
| 2014-05-12 | Popovits Kimberly J (President and CEO) | Sale | 3,000 | 26.78 | 80,331 |
| 2014-05-12 | Popovits Kimberly J (President and CEO) | Option Ex | 3,000 | 9.39 | 28,170 |
| 2014-05-09 | Schorno Dean L (CFO) | Sale | 4,000 | 25.09 | 100,360 |
| 2014-05-09 | Schorno Dean L (CFO) | Option Ex | 4,000 | 18.04 | 72,140 |
| 2014-04-14 | Shak Steven (EVP of R&D) | Sale | 7,000 | 26.52 | 185,654 |
| 2014-04-14 | Shak Steven (EVP of R&D) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2014-04-08 | Cole G Bradley (COO) | Sale | 3,000 | 27.00 | 81,000 |
| 2014-04-08 | Cole G Bradley (COO) | Option Ex | 3,000 | 2.88 | 8,640 |
| 2014-03-14 | Shak Steven (EVP of R&D) | Sale | 7,000 | 28.36 | 198,492 |
| 2014-03-14 | Shak Steven (EVP of R&D) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2014-03-10 | Cole G Bradley (COO) | Sale | 3,000 | 27.76 | 83,289 |
| 2014-03-10 | Cole G Bradley (COO) | Option Ex | 3,000 | 2.88 | 8,640 |
| 2014-02-18 | Hibbs Kathy L (SVP & General Counsel) | Sale | 1,312 | 27.88 | 36,583 |
| 2014-02-14 | Shak Steven (EVP of R&D) | Sale | 7,000 | 27.38 | 191,632 |
| 2014-02-14 | Shak Steven (EVP of R&D) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2014-02-10 | Cole G Bradley (COO) | Sale | 3,000 | 27.00 | 81,000 |
| 2014-02-10 | Cole G Bradley (COO) | Option Ex | 3,000 | 2.88 | 8,640 |
| 2014-01-15 | Shak Steven (EVP of R&D) | Sale | 7,000 | 31.51 | 220,598 |
| 2014-01-15 | Shak Steven (EVP of R&D) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2014-01-13 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 30.00 | 75,000 |
| 2014-01-13 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 9.39 | 23,475 |
| 2014-01-08 | Cole G Bradley (COO) | Sale | 3,000 | 28.17 | 84,501 |
| 2014-01-08 | Cole G Bradley (COO) | Option Ex | 3,000 | 2.88 | 8,640 |
| 2013-12-17 | Shak Steven (EVP of R&D & CMO) | Sale | 7,000 | 29.24 | 204,673 |
| 2013-12-17 | Shak Steven (EVP of R&D & CMO) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2013-12-16 | Shak Steven (EVP of R&D & CMO) | Sale | 7,000 | 29.91 | 209,349 |
| 2013-12-16 | Shak Steven (EVP of R&D & CMO) | Option Ex | 7,000 | 2.88 | 20,160 |
| 2013-12-12 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 30.68 | 76,705 |
| 2013-12-12 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 9.39 | 23,475 |
| 2013-12-09 | Schorno Dean L (CFO) | Sale | 3,000 | 33.25 | 99,762 |
| 2013-12-09 | Schorno Dean L (CFO) | Option Ex | 3,000 | 17.25 | 51,765 |
| 2013-12-02 | Livingston Randall S (Director) | Sale | 1,000 | 34.92 | 34,920 |
| 2013-12-02 | Livingston Randall S (Director) | Option Ex | 1,000 | 10.73 | 10,730 |
| 2013-11-13 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 35.00 | 87,500 |
| 2013-11-13 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 9.39 | 23,475 |
| 2013-11-12 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 34.17 | 85,422 |
| 2013-11-12 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 9.39 | 23,475 |
| 2013-11-08 | Schorno Dean L (CFO) | Sale | 3,000 | 33.36 | 100,089 |
| 2013-11-08 | Schorno Dean L (CFO) | Option Ex | 3,000 | 17.33 | 51,989 |
| 2013-11-06 | Cole G Bradley (COO) | Sale | 2,868 | 31.18 | 89,412 |
| 2013-11-06 | Cole G Bradley (COO) | Option Ex | 2,868 | 1.33 | 3,814 |
| 2013-10-15 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 29.67 | 148,340 |
| 2013-10-10 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 30.00 | 75,000 |
| 2013-10-10 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 6.13 | 15,337 |
| 2013-10-09 | Cole G Bradley (COO) | Sale | 2,500 | 29.95 | 74,885 |
| 2013-10-09 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-09-18 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 33.73 | 168,630 |
| 2013-09-12 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 34.31 | 85,787 |
| 2013-09-12 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 2.88 | 7,200 |
| 2013-09-09 | Cole G Bradley (COO) | Sale | 2,500 | 32.53 | 81,329 |
| 2013-09-09 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-09-06 | Schorno Dean L (CFO) | Sale | 4,000 | 32.90 | 131,600 |
| 2013-09-06 | Schorno Dean L (CFO) | Option Ex | 4,000 | 17.25 | 69,020 |
| 2013-09-03 | Livingston Randall S (Director) | Sale | 1,000 | 31.49 | 31,492 |
| 2013-09-03 | Livingston Randall S (Director) | Option Ex | 1,000 | 10.73 | 10,730 |
| 2013-08-14 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 32.98 | 164,905 |
| 2013-08-12 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 33.03 | 82,572 |
| 2013-08-12 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 2.88 | 7,200 |
| 2013-08-09 | Schorno Dean L (CFO) | Sale | 4,000 | 33.15 | 132,580 |
| 2013-08-09 | Schorno Dean L (CFO) | Option Ex | 4,000 | 17.18 | 68,720 |
| 2013-08-07 | Cole G Bradley (COO) | Sale | 2,500 | 33.66 | 84,140 |
| 2013-08-07 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-07-23 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 35.33 | 176,670 |
| 2013-07-12 | Popovits Kimberly J (President and CEO) | Sale | 2,100 | 35.00 | 73,500 |
| 2013-07-12 | Popovits Kimberly J (President and CEO) | Option Ex | 2,100 | 2.88 | 6,048 |
| 2013-07-11 | Popovits Kimberly J (President and CEO) | Sale | 2,900 | 34.32 | 99,528 |
| 2013-07-11 | Popovits Kimberly J (President and CEO) | Option Ex | 2,900 | 2.88 | 8,352 |
| 2013-07-09 | Schorno Dean L (CFO) | Sale | 4,000 | 33.81 | 135,236 |
| 2013-07-09 | Schorno Dean L (CFO) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2013-07-08 | Cole G Bradley (COO) | Sale | 2,500 | 33.33 | 83,327 |
| 2013-07-08 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-06-18 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 33.56 | 167,810 |
| 2013-06-10 | Schorno Dean L (CFO) | Sale | 4,000 | 35.88 | 143,524 |
| 2013-06-10 | Schorno Dean L (CFO) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2013-06-05 | Cole G Bradley (COO) | Sale | 2,500 | 36.47 | 91,172 |
| 2013-06-05 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-06-05 | Baker Bros Advisors Llc (Director) | Buy | 217,773 | 35.81 | 7,799,539 |
| 2013-06-04 | Baker Bros Advisors Llc (Director) | Buy | 163,659 | 36.62 | 5,993,192 |
| 2013-06-03 | Baker Bros Advisors Llc (Director) | Buy | 128,341 | 36.69 | 4,708,446 |
| 2013-06-03 | Livingston Randall S (Director) | Sale | 1,000 | 36.40 | 36,400 |
| 2013-06-03 | Livingston Randall S (Director) | Option Ex | 1,000 | 10.73 | 10,730 |
| 2013-05-31 | Baker Bros Advisors Llc (Director) | Buy | 51,242 | 36.75 | 1,883,245 |
| 2013-05-29 | Baker Bros Advisors Llc (Director) | Buy | 47,000 | 36.82 | 1,730,634 |
| 2013-05-28 | Baker Bros Advisors Llc (Director) | Buy | 74,266 | 36.93 | 2,742,940 |
| 2013-05-24 | Baker Bros Advisors Llc (Director) | Buy | 62,517 | 36.93 | 2,308,877 |
| 2013-05-23 | Baker Bros Advisors Llc (Director) | Buy | 16,900 | 36.59 | 618,286 |
| 2013-05-22 | Hibbs Kathy L (SVP & General Counsel) | Sale | 1,000 | 37.48 | 37,480 |
| 2013-05-22 | Hibbs Kathy L (SVP & General Counsel) | Option Ex | 1,000 | 21.07 | 21,070 |
| 2013-05-21 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 37.19 | 185,955 |
| 2013-05-16 | Baker Bros Advisors Llc (Director) | Buy | 19,306 | 36.54 | 705,421 |
| 2013-05-15 | Baker Bros Advisors Llc (Director) | Buy | 52,133 | 36.41 | 1,898,371 |
| 2013-05-15 | Livingston Randall S (Director) | Sale | 1,337 | 35.83 | 47,903 |
| 2013-05-15 | Livingston Randall S (Director) | Option Ex | 1,337 | 1.33 | 1,774 |
| 2013-05-14 | Baker Bros Advisors Llc (Director) | Buy | 27,184 | 35.53 | 965,901 |
| 2013-05-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 34.70 | 173,505 |
| 2013-05-13 | Popovits Kimberly J (President and CEO) | Option Ex | 5,000 | 2.88 | 14,400 |
| 2013-05-13 | Hibbs Kathy L (SVP & General Counsel) | Sale | 1,250 | 34.42 | 43,031 |
| 2013-05-13 | Hibbs Kathy L (SVP & General Counsel) | Option Ex | 1,250 | 21.07 | 26,337 |
| 2013-05-13 | Baker Bros Advisors Llc (Director) | Buy | 213,242 | 34.38 | 7,331,686 |
| 2013-05-09 | Schorno Dean L (CFO) | Sale | 4,000 | 36.02 | 144,088 |
| 2013-05-09 | Schorno Dean L (CFO) | Option Ex | 4,000 | 17.18 | 68,720 |
| 2013-05-08 | Cole G Bradley (COO) | Sale | 2,500 | 35.99 | 89,965 |
| 2013-05-08 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-04-23 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 30.00 | 75,000 |
| 2013-04-23 | Popovits Kimberly J (President and CEO) | Option Ex | 2,500 | 2.88 | 7,200 |
| 2013-04-03 | Cole G Bradley (COO) | Sale | 2,500 | 27.79 | 69,482 |
| 2013-04-03 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-03-06 | Cole G Bradley (COO) | Sale | 2,500 | 28.57 | 71,435 |
| 2013-03-06 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-02-21 | Baker Bros Advisors Llc (Director) | Buy | 28,200 | 27.64 | 779,335 |
| 2013-02-20 | Hibbs Kathy L (SVP & General Counsel) | Sale | 2,716 | 28.13 | 76,398 |
| 2013-02-20 | Baker Bros Advisors Llc (Director) | Buy | 20,885 | 27.97 | 584,216 |
| 2013-02-14 | Baker Bros Advisors Llc (Director) | Buy | 34,800 | 28.43 | 989,398 |
| 2013-02-14 | Myers Woodrow A Jr (Director) | Sale | 41,250 | 28.40 | 1,171,541 |
| 2013-02-14 | Myers Woodrow A Jr (Director) | Option Ex | 41,250 | 18.88 | 778,635 |
| 2013-02-13 | Baker Bros Advisors Llc (Director) | Buy | 17,200 | 28.58 | 491,593 |
| 2013-02-11 | Baker Bros Advisors Llc (Director) | Buy | 79,984 | 28.23 | 2,258,108 |
| 2013-02-08 | Baker Bros Advisors Llc (Director) | Buy | 36,376 | 27.96 | 1,017,109 |
| 2013-02-06 | Cole G Bradley (COO) | Sale | 2,500 | 28.03 | 70,077 |
| 2013-02-06 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2013-01-28 | Livingston Randall S (Director) | Sale | 2,000 | 28.77 | 57,544 |
| 2013-01-28 | Livingston Randall S (Director) | Option Ex | 2,000 | 1.33 | 2,654 |
| 2013-01-09 | Schorno Dean L (CFO) | Sale | 2,625 | 28.00 | 73,500 |
| 2013-01-09 | Schorno Dean L (CFO) | Option Ex | 2,625 | 9.39 | 24,648 |
| 2013-01-09 | Cole G Bradley (COO) | Sale | 2,500 | 27.88 | 69,695 |
| 2013-01-09 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-12-18 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 27.74 | 138,720 |
| 2012-12-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 28.09 | 140,440 |
| 2012-12-11 | Schorno Dean L (CFO) | Sale | 3,000 | 28.00 | 84,000 |
| 2012-12-11 | Schorno Dean L (CFO) | Option Ex | 3,000 | 9.39 | 28,170 |
| 2012-12-06 | Cole G Bradley (COO) | Sale | 2,500 | 27.18 | 67,947 |
| 2012-12-06 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-11-26 | Livingston Randall S (Director) | Sale | 2,000 | 27.84 | 55,684 |
| 2012-11-26 | Livingston Randall S (Director) | Option Ex | 2,000 | 1.33 | 2,654 |
| 2012-11-21 | Baker Bros Advisors Llc (Director) | Buy | 300 | 27.54 | 8,262 |
| 2012-11-20 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 27.17 | 135,845 |
| 2012-11-20 | Baker Bros Advisors Llc (Director) | Buy | 229,000 | 26.83 | 6,143,383 |
| 2012-11-20 | Colella Samuel D (Director) | Sale | 5,500 | 26.52 | 145,843 |
| 2012-11-19 | Colella Samuel D (Director) | Sale | 25,116 | 26.97 | 677,478 |
| 2012-11-14 | 667, L.p. (Director) | Buy | 103,167 | 27.32 | 2,818,212 |
Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.